HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: AJPH.2009.159889v1 99/12/2184    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hsu, A. Articles by Moran, A. PubMed PubMed Citation Articles by Hsu, A. Articles by Moran, A. Related Collections Women's Health Cardiovascular Disease

Angela Hsu, MD, Andrea Card, MD, Susan Xiaoqin Lin, DrPH, Sean Mota, BA, Olveen Carrasquillo, MD, MPH and Andrew Moran, MD, MPH

All authors are with Columbia Presbyterian Medical Center, New York, NY.

Correspondence: Correspondence can be sent to Andrew Moran, MD, MPH, Division of General Internal Medicine, PH 9 East Room 105, 622 W 168th St, New York, NY 10032 (e-mail: aem35{at}columbia.edu). Reprints can be ordered at http://www.ajph.org by clicking the "Reprints/Eprints" link.

After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999–2000 and 2003–2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P < .001) among women with CVD versus 3% (from 19.8 to 16.8%; P = .68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.